Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where I. de Mascarel is active.

Publication


Featured researches published by I. de Mascarel.


European Journal of Cancer | 1998

Obvious peritumoral emboli: an elusive prognostic factor reappraised. Multivariate analysis of 1320 node-negative breast cancers

I. de Mascarel; F. Bonichon; M. Durand; Louis Mauriac; G. MacGrogan; Isabelle Soubeyran; V. Picot; A. Avril; J. M. Coindre; M. Trojani

This study was conducted to determine the prognostic influence of obvious peritumoral vascular emboli as prospectively determined by a simple routine slide examination in patients with operable node-negative breast cancer. Obvious peritumoral emboli (OPE) were defined by the presence of neoplastic emboli within unequivocal vascular lumina (including both lymphatic spaces and blood capillaries) in areas adjacent to but outside the margins of the carcinoma. OPE were assessed routinely on 5 microns thick haematoxylin and eosin-stained sections for each of 1320 primary operable node-negative breast cancers from 1975 to 1992 at our institution. OPE and other prognostic variables (tumour size, SBR grade, oestrogen and progesterone receptor status) were correlated to overall survival (OS) and metastasis-free interval (MFI) by means of univariate and multivariate analysis with a median follow-up of 103 months. OPE were found in 19.5% of tumours. In univariate analysis, OPE were related to tumour size (P = 6.3 x 10(-5)) and histologic grade (P = 4.9 x 10(-7)). Statistically significant correlations were found with OS (P = 4.6 x 10(-5)) and MFI (P = 6.4 x 10(-9)). Furthermore, in multivariate analysis, OPE was an independent prognostic variable, the most predictive factor for MFI (P = 7.7 x 10(-7)) before tumour size and grade, and was second after tumour grade for OS (P = 0.002). This study on a large unicentric series and with a long follow-up confirms the prognostic significance of vascular emboli in patients with operable node-negative breast carcinoma. Importantly, vascular emboli were found to be accurately detectable by a simple routine and non-time-consuming method. Therefore, such obvious vascular emboli should be considered as an important cost-effective, prognostic variable in patients with node-negative breast carcinoma.


Gynecologie Obstetrique & Fertilite | 2008

Cancers du sein chez l’homme : à propos de 52 cas pris en charge à l’institut Bergonié de Bordeaux entre 1980 et 2004

C. Tunon de Lara; G. Goudy; G. MacGrogan; M. Durand; J.-M. Dilhuydy; A. Avril; E. Stoeckle; J.-E. Bussières; Marc Debled; I. de Mascarel; Louis Mauriac


Ejc Supplements | 2006

Prognostic value of Mib1 in a tissue microarray of 855 invasive breast carcinomas

G. MacGrogan; Desrousseaux; I. de Mascarel; S. Mathoulin Pélissier; M. Debled; L. Mauriac; M. Durand; C. Tunon de Lara; H. Laharie Mineur; Véronique Brouste


La femme jeune face au cancer du sein (Strasbourg, 3-5 novembre 2010), ISBN 978-2-915968-29-2 ; p. 218-223 | 2010

Carcinome canalaire in situ chez la femme jeune CCIS chez la femme jeune : fréquence, diagnostic et traitement

C. Tunon de Lara; G. MacGrogan; C. Breton-Callu; P. Lagarde; I. de Mascarel; A. Avril; Fra Société française de sénologie et de pathologie mammaire


Ejc Supplements | 2008

Breast conservation and long term survival after neo-adjuvant chemotherapy

M. Debled; L. Mauriac; I. de Mascarel; Véronique Brouste; F. Bonichon; A. Avril


Ejc Supplements | 2008

Prognostic significance of lymphovascular invasion in node-positive patients with primary operable breast cancer

F. Raqaqe; M. Debled; G. MacGrogan; Véronique Brouste; Isabelle Soubeyran; C. Tunon de Lara; L. Mauriac; I. de Mascarel


Ejc Supplements | 2008

PTEN Immunohistochemical detection in breast cancer

G. Macqroqan; Françoise Bonnet; I. de Mascarel; Nicolas Sevenet; Ghislaine Sierankowski; Véronique Brouste; M. Debled; Hervé Bonnefoi; L. Mauriac; Michel Longy


/data/revues/11631961/00130002/104/ | 2008

Radiologie des carcinomes intracanalaires : corrélations radio-histologiques. À propos d'une série de 909 cas

B. Barreau; C Feuga; M. H. Dilhuydy; V. Picot; G. MacGrogan; I. de Mascarel; Jean-Marie Dilhuydy; C. Tunon de Lara; E. Bussieres


/data/revues/03682315/00270004/403/ | 2008

Iconography : Les récidives après traitement des carcinomes intracanalaires du sein

O Jourdain; C. Tunon de Lara; N Quenel; E. Stöckle; E. Bussieres; A. Faucher; V Acharian; C Vilbas-Guegan; I. de Mascarel; M. Trojani; Jean-Marie Dilhuydy; A. Avril


/data/revues/03682315/00270004/403/ | 2008

Les récidives après traitement des carcinomes intracanalaires du sein

O Jourdain; C. Tunon de Lara; N Quenel; E. Stöckle; E. Bussieres; A. Faucher; V Acharian; C Vilbas-Guegan; I. de Mascarel; M. Trojani; Jean-Marie Dilhuydy; A. Avril

Collaboration


Dive into the I. de Mascarel's collaboration.

Top Co-Authors

Avatar

C. Tunon de Lara

Argonne National Laboratory

View shared research outputs
Top Co-Authors

Avatar

G. MacGrogan

Argonne National Laboratory

View shared research outputs
Top Co-Authors

Avatar

A. Avril

Argonne National Laboratory

View shared research outputs
Top Co-Authors

Avatar

E. Bussieres

Argonne National Laboratory

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Isabelle Soubeyran

Argonne National Laboratory

View shared research outputs
Top Co-Authors

Avatar

L. Mauriac

Argonne National Laboratory

View shared research outputs
Top Co-Authors

Avatar

M. Debled

Argonne National Laboratory

View shared research outputs
Top Co-Authors

Avatar

M. H. Dilhuydy

Argonne National Laboratory

View shared research outputs
Top Co-Authors

Avatar

Véronique Brouste

Argonne National Laboratory

View shared research outputs
Researchain Logo
Decentralizing Knowledge